Status:
COMPLETED
Addiction Health Evaluation And Disease Management (AHEAD) Study
Lead Sponsor:
Boston Medical Center
Collaborating Sponsors:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions:
Alcohol Dependence
Alcoholism
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The objective of this study is to test whether a chronic disease management (CDM) program for substance abusers in primary care leads to improved alcohol and drug-related outcomes (such as reduced con...
Detailed Description
Chronic disease management (CDM) is a collaborative, longitudinal, proven effective approach to the treatment of chronic medical illnesses that addresses individual patient and health systems barriers...
Eligibility Criteria
Inclusion
- 18 years of age or older
- Fluent in English or Spanish
- Alcohol or drug dependent
- Heavy drinking in the past 30 days or recent drug use
- Provide 2 contacts to assist with follow-up
- Have no plans to move from the local area within a year of screening
- Score \>21 on Mini-Mental State Examination (no serious cognitive impairment)
Exclusion
- Pregnant (self-report)
- Breath alcohol \>100 mg/dL
- Inability to provide informed consent determined by trained research associates
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2012
Estimated Enrollment :
569 Patients enrolled
Trial Details
Trial ID
NCT00278447
Start Date
April 1 2006
End Date
April 1 2012
Last Update
October 2 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Medical Center / Boston University
Boston, Massachusetts, United States, 02118